| ABO incompatible group | ABO compatible group |
Total no. of patients who exceeded follow up of 12 months | 18 | 21 |
Average follow up (in months) | 37.6 (17 to 66 months) | 38.9 (18 to 65 months) |
Average age (in years) | 36.7 (13 to 57 years) | 42.1 (17 to 64 years) |
Male | 11 | 17 |
Female | 7 | 4 |
Average serum creatinine at the end of follow-up | 1.3 mg/dl (0.8 to 2.0) | 1.3 mg/dl (0.7 to 1.9) |
Complications |
|
|
Gastroenteritis | 4 | 4 |
CMV infection | 1 | 1 |
UTI | 4 | 5 |
Tuberculosis | 2 | Nil |
NODM | 2 | 1 |
Epididymo-orchitis | Nil | 1 |
Gangrene | Nil | 1 |
Mortality | Nil | Nil |
Hospitalization | 5 | 6 |